613 related articles for article (PubMed ID: 34522211)
1. Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry.
Wang P; Zhou Y; Richards AM
Theranostics; 2021; 11(18):8771-8796. PubMed ID: 34522211
[TBL] [Abstract][Full Text] [Related]
2. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
Traber GM; Yu AM
J Pharmacol Exp Ther; 2023 Jan; 384(1):133-154. PubMed ID: 35680378
[TBL] [Abstract][Full Text] [Related]
3. Artificial miRNAs as therapeutic tools: Challenges and opportunities.
Kotowska-Zimmer A; Pewinska M; Olejniczak M
Wiley Interdiscip Rev RNA; 2021 Jul; 12(4):e1640. PubMed ID: 33386705
[TBL] [Abstract][Full Text] [Related]
4. Protocols for the Analysis of microRNA Expression, Biogenesis, and Function in Immune Cells.
Zhang N; Hu G; Myers TG; Williamson PR
Curr Protoc Immunol; 2019 Sep; 126(1):e78. PubMed ID: 31483103
[TBL] [Abstract][Full Text] [Related]
5. Examination of artificial MiRNA mimics with centered-site complementarity for gene targeting.
Zhang SG; Liu CY; Li L; Sun TW; Luo YG; Yun WJ; Zhang JY
PLoS One; 2013; 8(8):e72062. PubMed ID: 24013456
[TBL] [Abstract][Full Text] [Related]
6. The Growing Class of Novel RNAi Therapeutics.
Traber GM; Yu AM
Mol Pharmacol; 2024 Jun; 106(1):13-20. PubMed ID: 38719476
[TBL] [Abstract][Full Text] [Related]
7. The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.
Titze-de-Almeida R; David C; Titze-de-Almeida SS
Pharm Res; 2017 Jul; 34(7):1339-1363. PubMed ID: 28389707
[TBL] [Abstract][Full Text] [Related]
8. Argonaute 2-dependent Regulation of Gene Expression by Single-stranded miRNA Mimics.
Matsui M; Prakash TP; Corey DR
Mol Ther; 2016 May; 24(5):946-55. PubMed ID: 26903376
[TBL] [Abstract][Full Text] [Related]
9. RNA interference and cancer therapy.
Wang Z; Rao DD; Senzer N; Nemunaitis J
Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
[TBL] [Abstract][Full Text] [Related]
10. RNAi-based therapeutics and tumor targeted delivery in cancer.
Kara G; Calin GA; Ozpolat B
Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
[TBL] [Abstract][Full Text] [Related]
11. Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran.
Titze-de-Almeida SS; Brandão PRP; Faber I; Titze-de-Almeida R
Mol Diagn Ther; 2020 Feb; 24(1):49-59. PubMed ID: 31701435
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
De Paula D; Bentley MV; Mahato RI
RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
[TBL] [Abstract][Full Text] [Related]
13. siRNA therapeutics: a clinical reality.
Saw PE; Song EW
Sci China Life Sci; 2020 Apr; 63(4):485-500. PubMed ID: 31054052
[TBL] [Abstract][Full Text] [Related]
14. Small RNAs and non-small cell lung cancer.
Tong AW
Curr Mol Med; 2006 May; 6(3):339-49. PubMed ID: 16712479
[TBL] [Abstract][Full Text] [Related]
15. [RNA interference and molecular pathology of selected diseases].
Lochmanová J; Bartos M
Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485
[TBL] [Abstract][Full Text] [Related]
16. RNAi-based drug discovery and its application to therapeutics.
Hokaiwado N; Takeshita F; Banas A; Ochiya T
IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional gene silencing by siRNAs and miRNAs.
Filipowicz W; Jaskiewicz L; Kolb FA; Pillai RS
Curr Opin Struct Biol; 2005 Jun; 15(3):331-41. PubMed ID: 15925505
[TBL] [Abstract][Full Text] [Related]
18. Probing the microRNA and small interfering RNA pathways with virus-encoded suppressors of RNA silencing.
Dunoyer P; Lecellier CH; Parizotto EA; Himber C; Voinnet O
Plant Cell; 2004 May; 16(5):1235-50. PubMed ID: 15084715
[TBL] [Abstract][Full Text] [Related]
19. Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
Gorabi AM; Kiaie N; Aslani S; Jamialahmadi T; Johnston TP; Sahebkar A
J Autoimmun; 2020 Nov; 114():102529. PubMed ID: 32782117
[TBL] [Abstract][Full Text] [Related]
20. RNA interference (RNAi)-based plasmonic nanomaterials for cancer diagnosis and therapy.
Yoon J; Shin M; Lee JY; Lee SN; Choi JH; Choi JW
J Control Release; 2022 Feb; 342():228-240. PubMed ID: 35016917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
